Search research articles
Contact Us
Filters
Showing results (61-70 of 85) with videos related to
Page
of 9
Sort By:
The Journal of Biological Chemistry
|
December 20, 2005
Up-regulation of AMP-activated kinase by dysfunctional cystic fibrosis transmembrane conductance regulator in cystic fibrosis airway epithelial cells mitigates excessive inflammation
Kenneth R Hallows, Adam C Fitch, Christine A Richardson, et al.
Scientific Reports
|
October 27, 2016
Renoprotective Effects of Metformin are Independent of Organic Cation Transporters 1 &2 and AMP-activated Protein Kinase in the Kidney
Michael Christensen, Jonas B Jensen, Steen Jakobsen, et al.
Kidney360
|
July 28, 2021
Association of Baseline Urinary Metabolic Biomarkers with ADPKD Severity in TAME-PKD Clinical Trial Participants
Kenneth R Hallows, Andrew D Althouse, Hui Li, et al.
The Journal of Biological Chemistry
|
January 8, 2009
Regulation of epithelial Na+ transport by soluble adenylyl cyclase in kidney collecting duct cells
Kenneth R Hallows, Huamin Wang, Robert S Edinger, et al.
American Journal of Respiratory Cell and Molecular Biology
|
July 21, 2009
AMPK agonists ameliorate sodium and fluid transport and inflammation in cystic fibrosis airway epithelial cells
Michael M Myerburg, J Darwin King, Nicholas M Oyster, et al.
The Journal of Biological Chemistry
|
May 15, 2010
Phosphopeptide screen uncovers novel phosphorylation sites of Nedd4-2 that potentiate its inhibition of the epithelial Na+ channel
Kenneth R Hallows, Vivek Bhalla, Nicholas M Oyster, et al.
The Journal of Biological Chemistry
|
June 8, 2010
PKA regulates vacuolar H+-ATPase localization and activity via direct phosphorylation of the a subunit in kidney cells
Rodrigo Alzamora, Ramon F Thali, Fan Gong, et al.
Kidney International Reports
|
March 20, 2023
Association of Longitudinal Urinary Metabolic Biomarkers With ADPKD Severity and Response to Metformin in TAME-PKD Clinical Trial Participants
Kenneth R Hallows, Kaleab Z Abebe, Hui Li, et al.
Kidney International
|
June 29, 2021
Primary results of the randomized trial of metformin administration in polycystic kidney disease (TAME PKD)
Ronald D Perrone, Kaleab Z Abebe, Terry J Watnick, et al.
PNAS Nexus
|
May 29, 2024
Oral delivery of nanomedicine for genetic kidney disease
Yi Huang, Jonathan Wang, Valeria Mancino, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 85) with videos related to
Sort By:
Page
of 9
The Journal of Biological Chemistry
|
December 20, 2005
Up-regulation of AMP-activated kinase by dysfunctional cystic fibrosis transmembrane conductance regulator in cystic fibrosis airway epithelial cells mitigates excessive inflammation
Kenneth R Hallows, Adam C Fitch, Christine A Richardson, et al.
Scientific Reports
|
October 27, 2016
Renoprotective Effects of Metformin are Independent of Organic Cation Transporters 1 &2 and AMP-activated Protein Kinase in the Kidney
Michael Christensen, Jonas B Jensen, Steen Jakobsen, et al.
Kidney360
|
July 28, 2021
Association of Baseline Urinary Metabolic Biomarkers with ADPKD Severity in TAME-PKD Clinical Trial Participants
Kenneth R Hallows, Andrew D Althouse, Hui Li, et al.
The Journal of Biological Chemistry
|
January 8, 2009
Regulation of epithelial Na+ transport by soluble adenylyl cyclase in kidney collecting duct cells
Kenneth R Hallows, Huamin Wang, Robert S Edinger, et al.
American Journal of Respiratory Cell and Molecular Biology
|
July 21, 2009
AMPK agonists ameliorate sodium and fluid transport and inflammation in cystic fibrosis airway epithelial cells
Michael M Myerburg, J Darwin King, Nicholas M Oyster, et al.
The Journal of Biological Chemistry
|
May 15, 2010
Phosphopeptide screen uncovers novel phosphorylation sites of Nedd4-2 that potentiate its inhibition of the epithelial Na+ channel
Kenneth R Hallows, Vivek Bhalla, Nicholas M Oyster, et al.
The Journal of Biological Chemistry
|
June 8, 2010
PKA regulates vacuolar H+-ATPase localization and activity via direct phosphorylation of the a subunit in kidney cells
Rodrigo Alzamora, Ramon F Thali, Fan Gong, et al.
Kidney International Reports
|
March 20, 2023
Association of Longitudinal Urinary Metabolic Biomarkers With ADPKD Severity and Response to Metformin in TAME-PKD Clinical Trial Participants
Kenneth R Hallows, Kaleab Z Abebe, Hui Li, et al.
Kidney International
|
June 29, 2021
Primary results of the randomized trial of metformin administration in polycystic kidney disease (TAME PKD)
Ronald D Perrone, Kaleab Z Abebe, Terry J Watnick, et al.
PNAS Nexus
|
May 29, 2024
Oral delivery of nanomedicine for genetic kidney disease
Yi Huang, Jonathan Wang, Valeria Mancino, et al.
Page
of 9